|
Aldo Zini has been at the forefront of the technology revolution in hospital patient safety for more than 15 years, instrumental in driving change into a marketplace attached to the status quo. He continues that leadership as President and CEO of Aethon, a robotic engineering company that has developed an innovative automation platform to improve supply chain logistics. Aethon's current focus is healthcare, where its core product TUG is being used to automate the delivery of goods (meds, supplies, meals, equipment, etc.) in hospitals.
Zini's successes began long before taking the helm at Aethon. His contributions to technology driven companies have led to acquisitions worth more than a quarter of a billion dollars.
From 1991-96, he was the Vice President of Sales and Marketing for Automated Healthcare, which developed the first robotic medication dispensing system for hospitals (ROBOT-Rx) and was acquired by McKessonHBOC in 1996 for $67 million. He joined the founder during the early stage startup of this company and played a key role in VC funding, company and product development, product launch, sales and marketing.
From 1996-99, Zini assumed corporate responsibilities with McKessonHBOC as Senior Vice President of Marketing, where his Institutional Division's annual sales grew from $1 billion to $5 billion. Zini played a key role in building this company into one of the largest success stories in Pittsburgh. Automated Healthcare (now McKesson Automation Group) has generated more revenue and employed more people than any other technology company in the region over the last 15 years.
Before joining and investing in Aethon, he was Senior Vice President of Sales & Marketing for TechRX, the largest provider of software solutions to the pharmacy industry, which was sold to NDC Corporation for over $200 million.
In 2002, Zini invested in the start-up of Aethon founded by robot entrepreneur Henry Thorne and joined the company to lead its sales and marketing efforts. Soon after Aethon's first institutional funding, Zini became the company's President and CEO.
Zini owns several patents in medication dispensing technology, and is credited with the development of key methodologies in quantifying the value proposition for several technology platforms deployed in hundreds of hospitals across the country.
Zini received a BS in Industrial Engineering from the University of Pittsburgh and graduated with high honors from Carnegie-Mellon (1987), where he received a Master's in Public Management (Health Systems IT). | 